Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Siemens Healthineers

Ultrasound Derived Fat Fraction (UDFF) White Paper Delivering early liver diagnosis: the difference is in the details 

ACUSON Sequoia Reflection

MASLD (Metabolic dysfunction-associated steatotic liver disease) is the most common cause of chronic liver disease globally. 20% to 30% of people with a MASLD diagnosis progress to a MASH diagnosis (Metabolic dysfunction-associated steatohepatitis), which can lead to advanced fibrosis, cirrhosis, or liver failure with an estimated lifetime cost of $222B in inpatient care. 

Qualitative assessment of hepatic steatosis can be subjective. Conventional methods of ultrasound-based liver fat quantification can be difficult to understand. Ultrasound Derived Fat Fraction (UDFF) on the ACUSON Sequoia is fast, simple and intuitive. UDFF, with a total exam time of less than 1 minute, can classify hepatic steatosis as an index value greater than 5%*, delivering a similar clinical utility as MRI-PDFF1,2

Download the UDFF white paper to learn how to manage hepatic steatosis through liver fat quantification, to aid in successful clinical assessment. 

Complete the form below to download the UDFF liver ultrasound White Paper. 

*Required

*
1
2